# Evaluation of NeoRetina Artificial Intelligence Algorithm for the Screening of Diabetic Retinopathy at the CHUM

> **NCT04699864** · NA · RECRUITING · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 630 (estimated)

## Conditions studied

- Diabetic Retinopathy
- Diabetic Macular Edema
- Diabetic Maculopathy

## Interventions

- **DIAGNOSTIC_TEST:** Screening of DR and DME with artificial intelligence using NeoRetina
- **DIAGNOSTIC_TEST:** Routine ophthalmological evaluation of DR and DME
- **DIAGNOSTIC_TEST:** Manual grading of DR and DME by CHUM ophthalmologists based on retinal photographies acquired by Diagnos

## Key facts

- **NCT ID:** NCT04699864
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-10
- **Primary completion:** 2025-04
- **Final completion:** 2026-12
- **Target enrollment:** 630 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04699864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04699864, "Evaluation of NeoRetina Artificial Intelligence Algorithm for the Screening of Diabetic Retinopathy at the CHUM". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04699864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*